Aleafia Health Appoints New Lead Independent Director
October 02 2019 - 7:00AM
The Board of Directors of Aleafia Health Inc. (TSX: ALEF, OTC:
ALEAF, FRA: ARAH) (“
Aleafia Health” or the
“
Company”) has appointed Lea Ray as its new Lead
Independent Director. As previously announced on April 4,
2019, the role rotates among independent directors every six
months, as determined by a majority of the Company’s independent
directors. Loreto Grimaldi has acted as the Lead Independent
Director since April 4, 2019.
Ms. Ray, a Chartered Professional Accountant and seasoned board
director, holds an ICD.D designation from the Institute of
Corporate Directors. Over the past decade, she has held multiple
board leadership roles and currently chairs the Company’s Audit
Committee. Her financial career began with PricewaterhouseCoopers;
she is a former Vice-President, Corporate Finance of Warner Bros.
Entertainment Canada Inc., where she was employed for 19 years.
Ray has served on the Professional Conduct Committee of the
Chartered Professional Accountants (Ontario) and has also been a
board member and volunteer of several non-profit health,
conservation and community institutions.
“Lea’s leadership experience in corporate governance and finance
will provide tremendous value to Aleafia Health’s Board and the
Company as a whole,” said Aleafia Health Chairman Julian Fantino.
“I would also like to thank Loreto for his outstanding
contributions to the Company during his tenure as lead independent
director.”
The appointment of a Lead Independent Director supports Aleafia
Health’s goal of good corporate governance practices in accordance
with the guidelines set out in National Policy 58-201 Corporate
Governance Guidelines.
For Investor and Media Relations, please
contact:
Nicholas Bergamini, VP Investor Relations1-833-TSX-ALEF
(879-2533)IR@AleafiaHealth.comLEARN
MORE: www.AleafiaHealth.com
About Aleafia Health:
Aleafia Health is a leading, vertically integrated cannabis
health and wellness company with four primary business units:
Cannabis Cultivation & Products, Health & Wellness Clinics,
Cannabis Education, and Consumer Experience with ecommerce, retail
distribution and provincial supply agreements.
Aleafia Health owns three major cannabis product &
cultivation facilities, two of which are licensed and operational
including the first large-scale, operational outdoor cultivation
facility in Canadian history. The Company produces a diverse
portfolio of commercially proven, high-margin derivative products
including oils, capsules and sprays. Aleafia Health operates the
largest national network of medical cannabis clinics and education
centres staffed by MDs, nurse practitioners and educators and has
international operations in three continents.
Innovation is at the heart of Aleafia Health competitive
advantage. The Company maintains a medical cannabis dataset with
over 10 million data points to inform proprietary illness-specific
product development and its highly differentiated education
platform FoliEdge Academy. The Company is committed to creating
sustainable shareholder value and has been named the 2019 top
performing company of the year by the TSX Venture Exchange prior to
graduation to the TSX.